29/10/2026
On October 22, Chambers released the results of the Chambers Brazil Transactional 2026 guide. We are proud to share these recognitions, which reflect our excellence and our commitment to our clients. Ranked practice areas: Individual rankings: These results reaffirm the strength of our practice and the firm’s commitment to excellence across all of its areas. …
26/10/2026
The Oswaldo Cruz Foundation – Fiocruz, through its Immunobiological Technology Institute (Bio-Manguinhos), has issued Public Call No. 002/2026 to select private entities interested in Productive Development Partnerships (PDPs). The technologies covered are listed in Annex I of the Public Call Notice: the biopharmaceutical Pembrolizumab and the Herpes Zoster vaccine. Proposals must comply with the requirements …
23/10/2026
The Second Specialized Panel of the Federal Regional Court for the Second Circuit (TRF2), in ruling on Civil Appeal with Mandatory Review No. 5118116-31.2025.4.02.5101/RJ, held that, notwithstanding INPI/DIRPA Ordinance No. 14/2024, a patent application may be divided until an administrative appeal is filed against a rejection decision. This understanding is based on a combined reading …
23/10/2026
Week of October 19 to 23, 2026 The week revolved around the ban and the wait for the Supreme Court’s decision after the runoff. In parallel, the AGU advanced in court, the SPA/MF came under the spotlight in an anti-money laundering case, and sport looked for loopholes in the advertising ban. Below are the points …
19/10/2026
Anvisa has launched a public consultation on a proposed regulation establishing a regulatory sandbox framework within the Agency. The proposal aims to create a general procedure for the implementation of regulatory experimentation programs involving innovative products, services, processes, and business models subject to health surveillance regulation. The draft was submitted for public consultation following the …
16/10/2026
Week of October 12 to 16, 2026 Last week, the ban took effect. This week, the courts upheld it, the balance-return deadline arrived and Congress began debating how much of it will survive. Below are the points that deserve your attention. Ban update: what changed this week The deadline for banks and payment institutions to …
09/10/2026
Week of October 5 to 9, 2026 This was the first week under the ban. Since Tuesday, no authorized operator has been online, balance refunds have begun, and the dispute has moved to the federal courts and to Congress. Below is what deserves your attention. Ban in force: sites offline and balance refunds under way …
08/10/2026
The National Research Ethics Authority (INAEP, in Portuguese), together with Brazil’s Ministry of Health, has launched a public webpage to provide updates on the development of the new National Clinical Research Platform, a system that is expected to gradually replace Plataforma Brasil and operationalize the new governance framework established under Law No. 14,874/2024. The initiative …
06/10/2026
On October 5, 2026, Anvisa published RDC No. 1,045/2026, regulating Article 27, §2 of Law No. 6,360/1976, as amended by Law No. 15,154/2025, and establishing a simplified sanitary framework for artisanal personal care products, cosmetics, and perfumes. The regulation will enter into force 60 days after its publication, providing the sector with a transition period …
02/10/2026
The National Research Ethics Authority (INAEP) has issued its Technical Guidance on Single Ethical Review for Multicenter Research, providing important clarifications regarding the implementation of Brazil’s new clinical research regulatory framework. The document comes amid ongoing discussions among regulatory authorities, sponsors, CROs, research institutions, and Research Ethics Committees (RECs) concerning operational questions that remained following …